Evidence map›Paper›PMID 34444810›Full record

Trial reportNutrients2021

Metabolic and Anti-Inflammatory Protective Properties of Human Enriched Serum Following Artichoke Leaf Extract Absorption: Results from an Innovative Ex Vivo Clinical Trial.

Fabien Wauquier, Line Boutin-Wittrant, Aurélien Viret, Laure Guilhaudis, Hassan Oulyadi, Asma Bourafai-Aziez, Gwladys Charpentier, Guillaume Rousselot, Emmanuel Cassin, Stéphane Descamps and 4 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Agroprospecting of Biowastes: Globe Artichoke (Molecules (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Employment of GeneraNutrients · 2022
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Fabien WauquierClinic'n'Cell SAS, Faculty of Medicine and Pharmacy, TSA 50400, 28 Place Henri Dunant, CEDEX 1, F-63001 Clermont-Ferrand, France.
Line Boutin-WittrantClinic'n'Cell SAS, Faculty of Medicine and Pharmacy, TSA 50400, 28 Place Henri Dunant, CEDEX 1, F-63001 Clermont-Ferrand, France.
Aurélien ViretLaboratoire COBRA (UMR 6014 & FR 3038), CNRS, INSA de Rouen, UNIROUEN, Normandie Université, F-76821 Mont-Saint-Aignan, France.
Laure GuilhaudisLaboratoire COBRA (UMR 6014 & FR 3038), CNRS, INSA de Rouen, UNIROUEN, Normandie Université, F-76821 Mont-Saint-Aignan, France.ORCID 0000-0002-6212-9593
Hassan OulyadiLaboratoire COBRA (UMR 6014 & FR 3038), CNRS, INSA de Rouen, UNIROUEN, Normandie Université, F-76821 Mont-Saint-Aignan, France.ORCID 0000-0001-5813-1482
Asma Bourafai-AziezEVEAR EXTRACTION, 48 Route de Gennes, LD Félines, CEDEX 4, 49320 Coutures, France.ORCID 0000-0001-5974-7641
Gwladys CharpentierEVEAR EXTRACTION, 48 Route de Gennes, LD Félines, CEDEX 4, 49320 Coutures, France.
Guillaume RousselotEVEAR EXTRACTION, 48 Route de Gennes, LD Félines, CEDEX 4, 49320 Coutures, France.
Emmanuel CassinEVEAR EXTRACTION, 48 Route de Gennes, LD Félines, CEDEX 4, 49320 Coutures, France.
Stéphane DescampsCNRS, CHU Clermont Ferrand, ICCF, Clermont Auvergne INP, Université Clermont Auvergne, CEDEX 1, F-63000 Clermont-Ferrand, France.
Véronique RouxCIC INSERM 1405/Plateforme d'Investigation Clinique CHU Gabriel Montpied, 58 Rue Montalembert, CEDEX 1, F-63000 Clermont-Ferrand, France.
Nicolas MacianCIC INSERM 1405/Plateforme d'Investigation Clinique CHU Gabriel Montpied, 58 Rue Montalembert, CEDEX 1, F-63000 Clermont-Ferrand, France.
Gisèle PickeringCIC INSERM 1405/Plateforme d'Investigation Clinique CHU Gabriel Montpied, 58 Rue Montalembert, CEDEX 1, F-63000 Clermont-Ferrand, France.
Yohann WittrantINRAE, UMR 1019, UNH, CEDEX 1, F-63009 Clermont-Ferrand, France.ORCID 0000-0003-3811-8859
Centre National de la Recherche Scientifique · FRInformation Extraction & Transport (United States) · USInserm · FRLymphatic Education & Research Network · USUniversité Clermont Auvergne · FR

Funding

This project was funded by EVEAR Extraction. Contribution of Y.W. was supported by INRAE. Contribution of PIC/CIC was supported by Inserm and University Hospital. Contribution of A.V., L.G. and H.O. was financially supported by Rouen-Normandie University, ANR-11-LABX-0029
6 · The paper itself

Abstract

The aging of our population is accompanied by an increased prevalence of chronic diseases. Among those, liver, joint and adipose tissue-related pathologies have a major socio-economic impact. They share common origins as they result from a dysregulation of the inflammatory and metabolic status. Plant-derived nutrients and especially polyphenols, exert a large range of beneficial effects in the prevention of chronic diseases but require clinically validated approaches for optimized care management. In this study, we designed an innovative clinical approach considering the metabolites produced by the digestive tract following the ingestion of an artichoke leaf extract. Human serum, enriched with metabolites deriving from the extract, was collected and incubated with human hepatocytes, human primary chondrocytes and adipocytes to determine the biological activity of the extract. Changes in cellular behavior demonstrated that the artichoke leaf extract protects hepatocytes from lipotoxic stress, prevents adipocytes differentiation and hyperplasia, and exerts chondroprotective properties in an inflammatory context. These data validate the beneficial health properties of an artichoke leaf extract at the clinical level and provide both insights and further evidence that plant-derived nutrients and especially polyphenols from artichoke may represent a relevant alternative for nutritional strategies addressing chronic disease issues.

Indexed as

AdipocytesAdultAnti-Inflammatory AgentsCell ProliferationCholesterolChondrocytesCynara scolymusHepatocytesHep G2 CellsHumansLiverMetabolic DiseasesPlant ExtractsPlant LeavesPolyphenolsProtective AgentsAnti-Inflammatory AgentsCholesterolPlant ExtractsPolyphenolsProtective AgentsTriglyceridesadipocytesartichokechondrocytesclinical trialhepatocyteshuman cellsinflammationmetabolic disordersmetabolitesNMRpolyphenols

Identifiers

PMID34444810
PMCPMC8398945
OpenAlexW3193117342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.